We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

AstraZeneca Pharmaceuticals (Ireland) DAC

College Park House, 20 Nassau Street, Dublin 2,
Telephone: +353 1 609 7100
Fax: +353 1 679 6650
Medical Information Direct Line: 1800 800 899 Freephone
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +353(0)1 609 7100 Supply & non-medical enquiries
Medical Information Facsimile: +44 (0)1582 838 003
Patient Information Leaflet last updated on medicines.ie: 16/03/2017
PIL Meronem I.V. 500mg & 1 g

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 16/03/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - contraindications
  • Change to section 4 - possible side effects
  • Change to other sources of information section
  • Correction of spelling/typing errors
Updated on 31/03/2016 and displayed until 16/03/2017
Reasons for adding or updating:
  • Change to information about driving or using machinery
  • Change to date of revision
  • Change in co-marketing arrangement
  • Addition of information on reporting a side effect.
Updated on 06/10/2015 and displayed until 31/03/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to date of revision
Updated on 02/04/2015 and displayed until 06/10/2015
Reasons for adding or updating:
  • Change to storage instructions
  • Change to date of revision
  • Addition of information on reporting a side effect.
Updated on 23/09/2014 and displayed until 02/04/2015
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 28/04/2014 and displayed until 23/09/2014
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to further information section
  • Change to date of revision
  • Change to dosage and administration
  • Addition of information on reporting a side effect.
  • Improved electronic presentation
Updated on 24/06/2011 and displayed until 28/04/2014
Reasons for adding or updating:
  • Change to storage instructions
  • Change to marketing authorisation holder
Updated on 03/08/2010 and displayed until 24/06/2011
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 18/03/2009 and displayed until 03/08/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 02/07/2008 and displayed until 18/03/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 18/04/2007 and displayed until 02/07/2008
Reasons for adding or updating:
  • Change to marketing authorisation holder
Updated on 12/01/2006 and displayed until 18/04/2007
Reasons for adding or updating:
  • Change of active ingredient
  • Change to date of revision
  • Change from the BAN of the active substance to the rINN
Updated on 08/07/2005 and displayed until 12/01/2006
Reasons for adding or updating:
  • Change of manufacturer
Updated on 10/08/2004 and displayed until 08/07/2005
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Meropenem Trihydrate